Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Dosage
151 Bendamustine Hydrochloride 25mg/vial powder for concentrate for solution for infusion L01AA09110P3301XX A* Bendamustine is indicated for monotherapy in patients with indolent B-cell non-Hodgkin's lymphomas (iNHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Monotherapy for iNHL refractory to rituximab: 120mg/m2 body surface area bendamustine hydrochloride on days 1 and 2; every 3 weeks.
152 Benzalkonium 0.01% - 0.02% Cream D08AJ01000G1001XX B Prevention and treatment of nappy rash Wash and dry baby's bottom. Apply by spreading the cream evenly paying particular attention to the fold of the skin, after every nappy change
153 Benzalkonium Chloride Disinfectant Solution V07AV00100L9908XX C Low level disinfectant suitable for general cleaning and disinfection of hard surface Cleaning purposes: Dilute 1 in 10. Disinfection, use undiluted
154 Benzathine Penicillin 2.4 MIU (1.8 g) Injection J01CE08702P4001XX B i) Treatment of mild to moderately severe infections due to Penicillin G-sensitive organisms ii) Treatment of syphillis i) ADULT: 1.2 mega units IM ii) For syphillis: 2.4 mega units weekly for 1 - 3 weeks
155 Benzhexol 2 mg Tablet N04AA01110T1001XX B i) Parkinson's disease ii) Drug induced parkinsonism iii) Dystonias ADULT: Initially 1 mg daily, increase gradually. Maintenance: 5 - 15 mg daily in 3 - 4 divided doses. (Max 15mg/day)
156 Benzoic Acid Compound Half Strength (Paed) Ointment D01AE12952G5001XX C Tinea infections of the skin Apply sparingly to affected area once or twice daily
157 Benzoic Acid Compound Ointment D01AE12952G5002XX C Tinea infections of thickened skin of palms and soles Apply sparingly to affected area once or twice daily
158 Benzoin Compound Tincture D08AX00000L5001XX C Infected skin, lesions, cuts, abrasions, wounds and burns Apply undiluted to the skin 1 or 2 times daily. Duration of therapy, may be weeks to months depending on the infection being treated
159 Benzoyl Peroxide 10% Gel D10AE01241G3002XX B Mild to moderate acne vulgaris Apply 1-2 times daily preferably after washing with soap and water
160 Benzoyl Peroxide 5% Gel D10AE01241G3001XX B Mild to moderate acne vulgaris Apply 1-2 times daily preferably after washing with soap and water
161 Benzydamine HCl 0.15% Solution A01AD02110M2001XX B For relief of painful condition of the oral cavity Used as a 30 seconds gargle or rinse, undiluted. ADULT 15 ml. CHILD less 12 years 5-15 ml. Uninterrupted treatment should not be more than 7 days
162 Benzydamine Hydrochloride 3.0 mg/ml throat spray A01AD02110A4201XX A* Temporary relief of painful conditions of the mouth and throat including tonsillitis, sore throat, radiation mucositis, aphthous ulcers, pharyngitis, swelling, redness, inflammatory conditions, post-orosurgical and periodontal procedures. (For pediatric and otorhinolaringology use. Restrict to patients who are not able to gargle) ADULTS and CHILDREN OVER 12 YEARS: 2-4 sprays (1-2mg) directly onto the sore/inflamed area and swallow gently. Repeat every 1 1/2 to 3 hours as necessary. CHILDREN 6-12 YEARS: 2 sprays (1mg) directly onto sore/ inflamed area and swallow gently. Repeat every 11/2 to 3 hours as necessary. CHILDREN UNDER 6 YEARS: Not recommended. Uninterrupted treatment should not exceed seven days, unless under medical supervision
163 Benzyl Benzoate 12.5 % Emulsion (Child) P03AX01252L2001XX C Scabies - for child 2-12 years old After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases
164 Benzyl Benzoate 25 % Emulsion (Adult) P03AX01000L2002XX C+ Scabies for adult and children more than 12 years old. After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases.
165 Benzylpenicillin 1 mega unit (600 mg) Injection J01CE01702P4001XX B i) Infections caused by susceptible organisms ii) Infective endocarditis i) Adult: 600mg - 3600mg (1 - 6 mega units) daily, divided into 4 to 6 doses. Higher doses (24 mega units) in divided doses may be given in serious infections such as meningitis. Child 1 month to 12 years old: 100mg/kg/day in 4 divided doses, not exceeding 4g/day; Infants 1 -4 weeks: 75mg/kg/day in 3 divided doses; Newborn Infants: 50mg/kg/day in 2 divided doses ii)7.2 to 12g (12 - 20 mega units) maybe given daily in divided doses
166 Benzylpenicillin 10,000 units/ml Eye Drops S01AA14702D2002XX B Eye infection 1-2 drops every 15 minutes or accordingly to needs of the patient
167 Benzylpenicillin 2,500 units/ml (1.5 mg/ml) Eye Drops S01AA14702D2001XX B Eye infection 1-2 drops every 15 minutes or accordingly to needs of the patient
168 Benzylpenicillin 5 mega unit (3g) Injection J01CE01702P4002XX B i) Infections caused by susceptible organisms ii) Infective endocarditis i) ADULT: 600 - 1200 mg IM 4 times daily, increased if necessary in more serious infections. CHILD: 50 - 100 mg/kg body weight daily IV in 2 - 4 divided doses ii) ADULT: 7.2 g daily by slow IV infusion in 6 divided doses
169 Beractant Intratracheal Suspension (200 mg phospholipids in 8 ml vial) R07AA02000L8001XX A* Treatment of newborn baby with birth weight of 700 g or greater undergoing mechanical ventilation for respiratory distress syndrome, whose heart rate and arterial oxygenation are continuously monitored 100 mg/kg (4 ml/kg) body weight intratracheally up to 4 doses in 1st 48 hr. Doses should not be given more frequently than 6 hrly. To be administered as soon as possible.
170 Betahistine Dihydrochloride 16 mg Tablet N07CA01110T1002XX A/KK i) Meniere's Syndrome as defined by the following core symptoms: - Vertigo (with nausea/vomiting). - Hearing loss (Hardness of hearing). - Tinnitus (ringing in the ears) ii)Symptomatic treatment of vestibular vertigo Given in doses of 8 to 16 mg orally 3 times daily (total 24 to 48 mg/day) preferably with food. CHILD not recommended
171 Betahistine Dihydrochloride 24 mg Tablet N07CA01110T1003XX A* i) Meniere's Syndrome as defined by the following core symptoms: - Vertigo (with nausea/vomiting). - Hearing loss (Hardness of hearing). - Tinnitus (ringing in the ears) ii)Symptomatic treatment of vestibular vertigo 24-48mg in divided doses daily
172 Betahistine Dihydrochloride 8 mg Tablet N07CA01110T1001XX A/KK i) Meniere's Syndrome as defined by the following core symptoms: - Vertigo (with nausea/vomiting). - Hearing loss (Hardness of hearing). - Tinnitus (ringing in the ears) ii)Symptomatic treatment of vestibular vertigo Given in doses of 8 to 16 mg orally 3 times daily (total 24 to 48 mg/day) preferably with food. CHILD not recommended
173 Betamethasone 0.5 mg Tablet H02AB01000T1001XX A Suppression of inflammatory and allergic disorders, congenital adrenal hyperplasia, cerebral oedema 0.5 - 9 mg daily in divided doses. CHILD: 0.5 - 7.5 mg/m2/day divided every 6 - 12 hours
174 Betamethasone 17-Valerate 0.01-0.05% Cream D07AC01256G1001XX B Eczemas, prurigo nodularis, limited psoriasis in appropriate in sites Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs
175 Betamethasone 17-Valerate 0.01-0.05% Ointment D07AC01256G5001XX B Eczema, prurigo nodularis, limited psoriasis in appropriate in sites Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs
176 Betamethasone 17-Valerate 0.1% Cream D07AC01256G1002XX A Eczemas, prurigo nodularis, psoriasis (excluding widespread plaque psoriasis) Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs
177 Betamethasone 17-Valerate 0.1% Ointment D07AC01256G5002XX A Eczema, prurigo nodularis, psoriasis (excluding widespread plaque psoriasis) Apply sparingly to affected area 2-3 times daily then reduced to once daily when improvement occurs
178 Betamethasone Disodium Phoshate 0.1% Ear Drops S03BA03162D1001XX B Non-infected inflammatory conditions Apply 2 - 3 drops every 2 - 3 hours, reduce frequency when relief obtained
179 Betamethasone Disodium Phoshate 0.5% Ear Drops S03BA03162D1002XX B Non-infected inflammatory conditions Apply 2 - 3 drops every 2 - 3 hours, reduce frequency when relief obtained
180 Betamethasone Disodium Phosphate 0.1% Eye Drops S01BA06162D2001XX A Non-infected inflammatory conditions of the eyes 1 - 2 drops every 1 - 2 hours until controlled then reduce frequency

Halaman-halaman